CRCL stock saw a 12% increase in our data analysis this week.

The price of $CRCL stock increased by 12% this week, as indicated by data obtained from Polygon. Over the past week, $CRCL has been the 33rd most researched stock out of 50 tickers on Quiver Quantitative. Diving into the specifics of $CRCL, our data reveals intriguing insights that investors can find valuable.

In terms of insider trading activity, there have been a total of 38 transactions involving $CRCL stock on the open market within the last six months. Of these transactions, none were purchases, while all 38 were sales. Some notable insider sales include CATALYST GROUP VI, L.P. GENERAL selling 3,550,724 shares estimated at $104,036,213, and JEREMY ALLAIRE, Chairman and CEO, selling 1,939,972 shares for an estimated $91,826,247. Overall, there has been consistent selling activity among company insiders over the past six months.

Transitioning to hedge fund activity, a significant number of institutional investors have either added or reduced their positions in $CRCL stock in the most recent quarter. Noteworthy additions include SUSQUEHANNA INTERNATIONAL GROUP, LLP, who added 2,458,044 shares (+356.2%) to their portfolio in Q3 2025, and VANGUARD GROUP INC, who added 2,126,072 shares (+61.6%) in the same quarter. Conversely, GENERAL CATALYST GROUP MANAGEMENT, LLC decreased their position by 1,119,728 shares (-5.6%) in Q3 2025.

Congressional stock trading data shows minimal activity, with only one trade involving $CRCL stock by a member of Congress in the past six months. This lone transaction was a purchase made by REPRESENTATIVE ROBERT BRESNAHAN, who acquired up to $15,000 worth of $CRCL stock on 06/24.

Analyst ratings have been largely positive for $CRCL stock, with 8 firms issuing buy ratings compared to 1 firm issuing a sell rating. Recent reports from Wall Street analysts have been optimistic, with ratings such as “Overweight,” “Buy,” and “Outperform” being assigned to $CRCL. Additionally, analysts have provided price targets for $CRCL, with a median target of $130.0 based on data from the past six months. Analysts from various firms, including Goldman Sachs, Baird, and JP Morgan, have set price targets for $CRCL within this range.

In conclusion, while the $CRCL stock has seen a notable rise in price this week, it is critical to examine various factors such as insider trading activity, hedge fund involvement, congressional transactions, analyst ratings, and price targets to gain a comprehensive understanding of the stock’s performance and potential future trajectory. Investors should conduct thorough research and consider multiple data points before making any investment decisions.